What Corteva (CTVA)'s Rimisoxafen Deal With FMC Means For Shareholders

Simply Wall St.06-18

Earlier this week, FMC Corporation and Corteva, Inc. announced a co-exclusive supply and license agreement giving Corteva access to FMC’s rimisoxafen herbicide technology for corn and soybean markets ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2644805700?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/2023000-choice1-main-header/1585186651478","is_english":true,"pubTime":"2026-06-18 18:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2644805700","market":"us","top_or_hot":-1,"title":"What Corteva (CTVA)'s Rimisoxafen Deal With FMC Means For Shareholders","media":"Simply Wall St.","content":"<div>\n<p>Earlier this week, FMC Corporation and Corteva, Inc. announced a co-exclusive supply and license agreement giving Corteva access to FMC’s rimisoxafen herbicide technology for corn and soybean markets ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/materials/nyse-ctva/corteva/news/what-corteva-ctvas-rimisoxafen-deal-with-fmc-means-for-share\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Corteva (CTVA)'s Rimisoxafen Deal With FMC Means For Shareholders</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Corteva (CTVA)'s Rimisoxafen Deal With FMC Means For Shareholders\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-18 18:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/materials/nyse-ctva/corteva/news/what-corteva-ctvas-rimisoxafen-deal-with-fmc-means-for-share><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Earlier this week, FMC Corporation and Corteva, Inc. announced a co-exclusive supply and license agreement giving Corteva access to FMC’s rimisoxafen herbicide technology for corn and soybean markets ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/materials/nyse-ctva/corteva/news/what-corteva-ctvas-rimisoxafen-deal-with-fmc-means-for-share\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0612318385.USD","symbol_name":"BGF NATURAL RESOURCES \"A2\" (USD) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/us/materials/nyse-ctva/corteva/news/what-corteva-ctvas-rimisoxafen-deal-with-fmc-means-for-share","article_id":"2644805700","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/2023000-choice1-main-header/1585186651478"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-ctva/corteva/news/what-corteva-ctvas-rimisoxafen-deal-with-fmc-means-for-share","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2644805700","pubTimestamp":1781778661,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Earlier this week, FMC Corporation and Corteva, Inc. announced a co-exclusive supply and license agreement giving Corteva access to FMC’s rimisoxafen herbicide technology for corn and soybean markets across North and South America, including an initial US$200,000,000 prepurchase commitment.\nThis agreement broadens Corteva’s weed-control toolkit with a differentiated active ingredient targeting resistant species, potentially reinforcing its crop protection franchise alongside ongoing...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0612318385.USD":"BGF NATURAL RESOURCES \"A2\" (USD) ACC","FMC":"FMC Corp.","AGIX":"通用人工智能 ETF-AGIX","CTVA":"Corteva, Inc.","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","BK4093":"化肥与农用药剂","BK4585":"ETF&股票定投概念","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU1430597077.USD":"BGF NATURAL RESOURCES \"A\" (USD) INC","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","BK4545":"锂电池","LU0471298777.SGD":"Blackrock Nutrition A2 SGD-H","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","LU0345780950.USD":"NINETY ONE GSF GLOBAL NATURAL RESOURCES \"A\" (USD) ACC","LU0654597011.USD":"BGF NATURAL RESOURCES \"A4G\" (USD) INC","ARTY":"ISHARES FUTURE AI & TECH ETF","AIPO":"Defiance AI and Power Infrastructure ETF","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","LU0300736492.USD":"FRANKLIN NATURAL RESOURCES \"A\" (USD) INC","LU0612318971.USD":"BGF NATURAL RESOURCES \"A5G\" (USD) INC","BK4535":"淡马锡持仓","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC","LU0300736062.USD":"FRANKLIN NATURAL RESOURCES \"A\" (USD) ACC","LU0385154629.USD":"贝莱德营养科学基金A2","LU0345781412.USD":"NINETY ONE GSF GLOBAL NATURAL RESOURCES \"A\" (USD) INC","LU2211817866.USD":"Allianz Food Security AT Acc USD","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","BK4588":"碎股","SG9999002521.SGD":"United Global Resources A Acc SGD","LU0630314457.HKD":"NINETY ONE GSF GLOBAL NATURAL RESOURCES \"A\" (HKD) ACC"},"translate_title":"Corteva(CTVA)与FMC的利米沙芬交易对股东意味着什么","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CHAT":0.62,"ARTY":0.62,"AGIX":0.62,"AIPO":0.72,"FMC":1.5,"CTVA":1.5},"content_text":"Earlier this week, FMC Corporation and Corteva, Inc. announced a co-exclusive supply and license agreement giving Corteva access to FMC’s rimisoxafen herbicide technology for corn and soybean markets across North and South America, including an initial US$200,000,000 prepurchase commitment. This agreement broadens Corteva’s weed-control toolkit with a differentiated active ingredient targeting resistant species, potentially reinforcing its crop protection franchise alongside ongoing restructuring efforts. Next, we’ll examine how adding rimisoxafen to Corteva’s portfolio could influence its investment narrative built around innovation and margin expansion. Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.AdvertisementCorteva Investment Narrative RecapTo own Corteva, you need to be comfortable with a steady, innovation led story in seeds and crop protection while the company restructures and prepares to split its businesses. The rimisoxafen deal strengthens the crop protection pipeline, but with first sales expected only near the end of the decade, it does not materially change the near term focus on executing restructuring plans and managing ongoing pricing and competitive pressures in Crop Protection. The recent announcement of higher restructuring charges and the closure of the Asturias facility is the most relevant backdrop for this agreement, as Corteva is trying to streamline manufacturing while keeping its innovation engine supplied with differentiated chemistries. Adding rimisoxafen fits with that push toward a higher value product mix, but investors still have to weigh these long term benefits against the cash outflows and earnings volatility associated with the multi year restructuring program. Yet investors should also be aware of the risk that ongoing price pressure in Crop Protection could... Read the full narrative on Corteva (it's free!)Corteva's narrative projects $19.5 billion revenue and $2.4 billion earnings by 2029. This requires 2.9% yearly revenue growth and about a $1.1 billion earnings increase from $1.3 billion today.Uncover how Corteva's forecasts yield a $90.05 fair value, a 16% upside to its current price.Exploring Other PerspectivesCTVA 1-Year Stock Price Chart Two fair value estimates from the Simply Wall St Community span roughly US$90 to US$107 per share, showing how widely individual views can differ. You should weigh these against Corteva’s reliance on cost cutting and productivity gains to support margins, and consider how that focus might affect the business if easy savings become harder to find over time.Explore 2 other fair value estimates on Corteva - why the stock might be worth just $90.05!Decide For YourselfDisagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.A great starting point for your Corteva research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.Our free Corteva research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Corteva's overall financial health at a glance.No Opportunity In Corteva?Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:Capitalize on the AI infrastructure supercycle with our selection of the 49 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.Uncover the next big thing with 24 elite penny stocks that balance risk and reward.We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2644805700","isCrawlerRequest":true}